Follow
Viktória E. Tóth
Viktória E. Tóth
Research associate, Semmelweis University, Department of Pharmacology and Pharmacotherapy
No verified email
Title
Cited by
Cited by
Year
Gut inflammation: current update on pathophysiology, molecular mechanism and pharmacological treatment modalities
K Gyires, E Viktoria Toth, S Zoltan Zadori
Current pharmaceutical design 20 (7), 1063-1081, 2014
642014
Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low …
Z Onódi, T Visnovitz, B Kiss, S Hambalkó, A Koncz, B Ágg, B Váradi, ...
Journal of Molecular and Cellular Cardiology 165, 19-30, 2022
552022
AIM2-driven inflammasome activation in heart failure
Z Onódi, M Ruppert, D Kucsera, AA Sayour, VE Tóth, G Koncsos, J Novák, ...
Cardiovascular research 117 (13), 2639-2651, 2021
502021
Evidence of a myenteric plexus barrier and its macrophage-dependent degradation during murine colitis: implications in enteric neuroinflammation
D Dora, S Ferenczi, R Stavely, VE Toth, ZV Varga, T Kovacs, I Bodi, ...
Cellular and Molecular Gastroenterology and Hepatology 12 (5), 1617-1641, 2021
352021
Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats
K Gyires, AZ Rónai, ZS Zádori, VE Tóth, J Németh, M Szekeres, ...
Molecular and cellular endocrinology 382 (2), 971-978, 2014
242014
Imidazoline versus alpha2-adrenoceptors in the control of gastric motility in mice
ZS Zádori, Á Fehér, M Al-Khrasani, E Lackó, VE Tóth, SB Brancati, L Hein, ...
European journal of pharmacology 705 (1-3), 61-67, 2013
232013
Characterization of immune checkpoint inhibitor‐induced cardiotoxicity reveals interleukin‐17A as a driver of cardiac dysfunction after anti‐PD‐1 treatment
TG Gergely, D Kucsera, VE Tóth, T Kovács, NV Sayour, ZD Drobni, ...
British Journal of Pharmacology 180 (6), 740-761, 2023
182023
Evidence for the gastric cytoprotective effect of centrally injected agmatine
ZS Zádori, VE Tóth, Á Fehér, K Philipp, J Németh, K Gyires
Brain research bulletin 108, 51-59, 2014
132014
Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system
ACM van Esbroeck, ZV Varga, X Di, EJ van Rooden, VE Tóth, Z Onódi, ...
Pharmacological research 151, 104578, 2020
122020
Characterization of the CDAA diet-induced non-alcoholic steatohepatitis model: Sex-specific differences in inflammation, fibrosis, and cholesterol metabolism in middle-aged mice
D Kucsera, VE Tóth, D Gergő, I Vörös, Z Onódi, A Görbe, P Ferdinandy, ...
Frontiers in Physiology 12, 609465, 2021
102021
Inhibition of α2A-Adrenoceptors Ameliorates Dextran Sulfate Sodium–Induced Acute Intestinal Inflammation in Mice
ZS Zádori, VE Tóth, Á Fehér, M Al-Khrasani, Z Puskár, M Kozsurek, ...
Journal of Pharmacology and Experimental Therapeutics 358 (3), 483-491, 2016
72016
IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH
D Kucsera, VE Tóth, NV Sayour, T Kovács, TG Gergely, M Ruppert, ...
Scientific Reports 13 (1), 356, 2023
42023
Saxagliptin cardiotoxicity in chronic heart failure: the role of DPP4 in the regulation of neuropeptide tone
I Vörös, Z Onódi, VÉ Tóth, TG Gergely, É Sághy, A Görbe, Á Kemény, ...
Biomedicines 10 (7), 1573, 2022
42022
Analysing the effect of I1 imidazoline receptor ligands on DSS-induced acute colitis in mice
Á Fehér, VE Tóth, M Al-Khrasani, M Balogh, B Lázár, Z Helyes, K Gyires, ...
Inflammopharmacology 25, 107-118, 2017
42017
Modulation of central endocannabinoid system results in gastric mucosal protection in the rat
VE Tóth, Á Fehér, J Németh, I Gyertyán, ZS Zádori, K Gyires
Brain Research Bulletin 139, 224-234, 2018
32018
Droplet Digital PCR Is a Novel Screening Method Identifying Potential Cardiac G-Protein-Coupled Receptors as Candidate Pharmacological Targets in a Rat Model of Pressure …
NV Sayour, VÉ Tóth, RN Nagy, I Vörös, TG Gergely, Z Onódi, N Nagy, ...
International Journal of Molecular Sciences 24 (18), 13826, 2023
22023
Depletion of muscularis macrophages ameliorates inflammation-driven dysmotility in murine colitis model
S Ferenczi, F Mogor, P Takacs, T Kovacs, VE Toth, ZV Varga, K Kovács, ...
Scientific Reports 13 (1), 22451, 2023
12023
NASH triggers cardiometabolic HFpEF in aging mice
D Kucsera, M Ruppert, NV Sayour, VE Tóth, T Kovács, ZI Hegedűs, ...
GeroScience, 1-15, 2024
2024
Novel druggable targets of heart failure with reduced ejection fraction identified by next generation sequencing and validated by droplet digital PCR
N Sayour, VE Tóth, N Nagy, C Bödör, B Váradi, B Ágg, M Ruppert, ...
Journal of Molecular and Cellular Cardiology 173, S154, 2022
2022
Molecular determinants of immune checkpoint inhibitor-induced cardiac dysfunction: comparison of PD-1 inhibitor treated C57BL/6J and BALB/c mice
TG Gergely, D Kucsera, VE Tóth, M Ruppert, B Petrovich, B Ágg, Z Onódi, ...
Journal of Molecular and Cellular Cardiology 173, S138, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20